Andrew Forrest’s Minderoo Foundation has participated in a $32 million funding round for a biotech company focused on preventative treatments for respiratory infections.

Andrew Forrest’s Minderoo Foundation has participated in a $32 million funding round for a biotech company focused on preventative treatments for respiratory infections.